J. H. Kim

Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma

Doo‐Sik Kong, J.-I. Lee, J. H. Kim et al. · Neuro-Oncology · 2010 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

J. Lee, Young‐Hyuck Im, Se‐Hoon Lee et al. · Cancer Chemotherapy and Pharmacology · 2007 · 61 citations

Medicine, Oncology, Breast Oncology +16

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

S-H Lee, W. Kang, Jinny Park et al. · British Journal of Cancer · 2004 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma

Jungwan Cho, Sun Young Kim, Y. J. Kim et al. · Clinical & Translational Oncology · 2017 · 15 citations

Medicine, Genetics, Oncology +16

Secondary abdominal pregnancy with foetal mummification diagnosed using computed tomography in a dog: a case report

Ho-Jin Myung, A.J. Lee, J. Y. Kim et al. · Veterinární Medicína · 2016 · 13 citations · Full text

Veterinary Medicine, Veterinary Diagnostic Imaging, Veterinary Surgery +10